Site Search

805 results for access website quick PROBLEMGO.com release from jail before court date cash

Deposits to the Fidelity Special Situations mutual fund are being limited but the segregated fund is
Fidelity Investments^® recently said they would no longer accept deposits from new investors into the Fidelity^® Special Situations Fund. This notice however does not affect Equitable Life^® clients.

The Special Situations Fund will continue to be open to new and existing Equitable Life clients. This includes clients with Pivotal Select™, Pivotal Solutions* or Personal Investment Portfolio segregated funds contracts.

Why is Fidelity limiting access to the mutual fund?
This award-winning mutual fund has grown significantly and now has $3.6 billion of managed assets. To preserve the integrity of the fund’s investment strategy, Fidelity^® decided to limit inflows to the fund. Limiting the amount of managed assets held within the fund allows the fund’s portfolio manager to focus on what he does best - finding special situation investment opportunities and capitalizing on positive change within companies and industries across Canada and around the world.

If you like the Special Situations mutual fund, you will value the Equitable Life Fidelity^® Special Situations segregated fund. Segregated funds are similar to mutual funds but offer different features and guarantees. To learn about these features, check out the Investment Advantage. To learn more about the Special Situations segregated fund, click here.

For more information about Equitable Life’s segregated funds, speak to your Regional Investment Sales Manager or visit our segregated funds page on EquiNet^®.

References:
Fidelity’s press release announcing the limited fund closure
Fidelity^® Special Situations portfolio management strategy, webinar featuring Mark Schmehl, Portfolio Manager.

*No Load, Deferred Sales Charge, Pivotal Solutions II
® or ™ denotes a trademark of The Equitable Life Insurance Company of Canada, except as noted below.
Fidelity and Fidelity Investments are registered trademarks of 483A Bay Street Holdings LP. Used with permission.
[pdf] Equitable GIF Advisor Guide
[pdf] Pivotal Select Application - TFSA
[pdf] Withdrawal Request
Term vs permanent life insurance: helping clients choose the best solution for them Most people understand why life insurance matters. What they’re often unsure about is which type of coverage is right for them. As an advisor, you’re in a unique position to do more than present options, you can help clients feel confident they’re making an informed choice.

Start with the client, not the product
Before discussing insurance solutions, you can start by asking three important questions:
1. What do you need to protect today?
2. What are you trying to achieve for the future?
3. What is your budget?
By asking these questions you will get a better understanding of which solution fits the client’s needs.

Matching the solution to the client
Term life insurance may be ideal for clients who have budget considerations and need coverage for:
• Helping to replace income
• Helping cover a mortgage or other debts
• Business protection
• A specific period of time (10 – 30 years)
If a client wants lifetime coverage but can’t afford it right now, term insurance is a good option. It gives them affordable coverage today that they can later choose to convert to permanent insurance when their income increases.¹

Permanent life insurance (whole life and universal life) is an option for clients looking for lifelong coverage and added long-term value. It’s a good option for clients who want to:
• Build an inheritance
• Preserve their estate
• Build tax advantaged cash value growth

Permanent life insurance is also an excellent way for parents or grandparents to help give children or grandchildren some lasting financial security. It secures lifetime protection at a lower cost when the child is young and healthy. It also offers the potential for cash value growth that they can access if needed.

Helping clients make confident choices
By focusing on what the client needs now—and what they might need later—you can help them pick life insurance that fits their changing life and financial goals. Share this client‑friendly piece that outlines some of the things that clients should consider to make an informed decision:
Which life insurance solution is right for you?

Reminder: Clients’ needs can change; it’s a good idea to review their coverage regularly.

For any questions, contact your Equitable wholesaler.

¹See contract for details on conversion limitations and eligibility.
Are your clients looking for more Tax-Free Savings Account contribution room?
Good news! With the start of the new year comes new additional contribution room. And to make it even better the Government of Canada increased the annual contribution limit. Effective January 1, 2023, the annual limit goes from $6,000.00 to $6,500.00.

A Tax-Free Savings Account is a great option for clients to grow their savings with the flexibility to access their money when they need it, before or during retirement. Encourage your clients to start saving today!

For more information on the options available, please click here.

Posted: January 3, 2023
[pdf] GIA Laddering Option

February 2020 Advisor eNews

In this issue:

Provincial biosimilar update
Legislative changes for Alberta’s Coverage for Seniors program
Coming soon: enhancements to Equitable EZClaim® Online

Provincial biosimilar update

Alberta Biosimilar Initiative

On December 12, 2019, the Alberta government introduced the launch of the Alberta Biosimilar Initiative. This program will require patients using several originator biologic drugs to switch to a biosimilar, and patients using a non-biologic complex drug (NBCD) to switch to its subsequent entry version before July 1, 2020 in order to maintain coverage.

Biologics are drugs that are engineered using living organisms like yeast and bacteria. The first version of a biologic developed is also known as the “originator” drug. Biosimilars are highly similar to the originator drug they are based on and have been shown to have no clinically meaningful differences in safety or efficacy.

Alberta Health will initially cover both the originator and biosimilar or subsequent entry version of a NBCD drug as patients start the switching process.

The following table outlines the affected originator drugs, their biosimilars or subsequent entry, and the conditions affected by the program.

Biosimilar Drug	Originator	Biosimilar/Subsequent Entry	Indications Affected
etanercept	Enbrel	Brenzys	Ankylosing Spondylitis Rheumatoid Arthritis
etanercept	Enbrel	Erelzi	Ankylosing Spondylitis Psoriatic Arthritis Rheumatoid Arthritis
infliximab	Remicade	Inflectra Renflexis	Ankylosing Spondylitis Plaque Psoriasis Psoriatic Arthritis Rheumatoid Arthritis Crohn’s Disease Ulcerative Colitis
insulin glargine	Lantus	Basaglar	Diabetes (Type 1 and 2)
Filgrastim	Neupogen	Grastofil	Neutropenia
pegfilgrastim	Neulasta	Lapelga	Neutropenia
glatiramer*	Copaxone	Glatect	Multiple Sclerosis

*Glatiramer is a non-biologic complex drug where the originator is Copaxone and the subsequent entry is Glatect.

Equitable Life is actively investigating the benefit, risk and appropriate plan changes associated with this new policy on private drug plans and will keep you informed.

For more information about the Alberta Biosimilars Initiative, consult the Alberta government website.

British Columbia

In 2019, BC Pharmacare introduced a Biosimilars Policy that impacted coverage of three biologic drugs – Remicade, Enbrel and Lantus. As of November 25, 2019, these drugs were no longer eligible in BC for most conditions for which lower cost biosimilar versions are available. Patients in the province with these conditions were required to switch to biosimilar versions of these drugs in order to maintain their coverage.

The second phase of the BC Biosimilar Policy takes effect March 6, 2020 when Remicade will be delisted for Crohn’s Disease and Ulcerative Colitis. Patients in the province with these conditions will be required to switch to Inflectra or Renflexis in order to maintain their coverage.

Biosimilar Drug	Originator	Biosimilar	Indications Affected
infliximab	Remicade	Inflectra Renflexis	Crohn’s Disease Ulcerative Colitis

We have communicated with the affected plan members, informing them of the need to switch medications. If plan members have any questions or concerns, our Customer Care team is here to help and support them through the transition.

If you have any questions about this policy, please contact your Group Account Executive or myFlex Sales Manager.

Ontario

In November 2019 Ontario Minister of Health Christine Elliot indicated that the government was planning to launch consultations to explore solutions in managing biologics.

Equitable Life will continue to monitor these developments and keep you informed of any impact on private drug plans.

Legislative changes for Alberta’s Coverage for Seniors program

The government of Alberta has announced that as of March 1, 2020, seniors’ family members (such as spouses and dependents) who are younger than 65 will no longer be covered by the provincial Coverage for Seniors program. Albertans 65 years of age and older will continue to be covered under the provincial plan.

Equitable Life plan members and their dependents will continue to be covered under the parameters of their group benefits plan.

For more information, please see the Alberta Seniors Health Benefits website.

Coming soon: enhancements to Equitable EZClaim^® Online

Faster vision claims processing and payment

Equitable Life will soon provide real-time processing of vision claims submitted via EZClaim Online.

This means plan members will be able to find out the status of their vision claim almost instantaneously. And, for approved claims, they will receive payment even sooner – often in as little as 24 hours.

In order to allow for instantaneous processing and faster payment, plan members will be prompted to enter some additional information including the practitioner’s name, the date of the expense, the type of expense and amount of the expense when submitting their claims for these services.

Equitable Life plan members can submit all vision claims via EZClaim, including coordination of benefits and Health Care Spending Account claims.

This enhancement will be coming to our EZClaim Mobile app in the coming months.

New printable claims extract

As part of our ongoing efforts to improve customer experience for plan members, we will also offer a claims extract in a printable format within the plan member site. Plan members will be able to select a date range and claimant, then generate and download a detailed list of health and dental claims. This is a helpful way to keep track of claims, especially when reviewing them in preparation for income tax filing.

Once these enhancements are live you will be notified in an eNews, and an announcement will be posted on the plan member section of EquitableHealth.ca.

Elimination of Out-of-Country Travellers Program in Ontario

Effective January 1, 2020, the Ontario government eliminated OHIP coverage for emergency services for Ontarians travelling outside of Canada.

Previously, the Out-of-Country Travelers Program provided some reimbursement for services required to treat conditions that are acute, unexpected, arose outside Canada and require immediate treatment. The program covered between $200 and $400 per day for inpatient services and $50 per day for outpatient and doctor services.

For groups who have out-of-country coverage from Allianz, this change will not impact the cost to your plan members, or the process plan members follow in the event of an emergency while travelling.

Plan members should still call Allianz in the event of an out of country emergency. Allianz will deal with their claim as usual and will now pay for the portion of the claim previously paid by OHIP. Plan members will not have any additional out-of-pocket costs.

We will be sharing this information with plan members as a news item on our plan member website, equitablehealth.ca.

December 30 Deadline for 7% No Load CB5 Initial Commission for Investment Class (75/75)
As the end of year approaches, so does the temporary increase to our CB5 sales option initial commission from 5.6% to 7.0% on Pivotal Select™ Investment Class (75/75). The 7% initial commission promotion will end on December 30, 2022.*
- Deposits and transfers to CB5 funds for Pivotal Select Investment Class (75/75) must be made by December 30, 2022, at 11:00 a.m. ET. Any deposits received after this date will not receive the promotional rate.
- Applications submitted before the December 30, 2022, deadline will only receive the promotional rate if also funded before December 30, 2022.
- If the client is awaiting a transfer from another financial institution, please follow up with the institution to ensure the transfer arrives by December 30, 2022.
For more information, please contact your Equitable Life Regional Investment Sales Manager.

* Equitable Life reserves the right to end the campaign, at any time and without notice.

™ or ® denote trademarks of The Equitable Life Insurance Company of Canada.

November 24, 2022
[pdf] Equitable GIF Advisor FAQ